Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1987-02-24
1989-08-01
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 854, A61K 4502
Patent
active
048532185
ABSTRACT:
An insoluble zinc-protamine alpha interferon complex useful as an injectable sustained release dosage form for administering alpha interferon is disclosed.
REFERENCES:
patent: 3912807 (1975-10-01), Alhern et al.
patent: 4289690 (1981-09-01), Pestka et al.
patent: 4496537 (1985-01-01), Kwan
patent: 4605555 (1984-09-01), Sato et al.
CA, vol. 103, No. 13, Sep. 30, 1985, Abst. 99718v.
Nagata et al., Nature, vol. 284, pp. 316-320.
Rubenstein, Biochimica et Biophysica Acta, 696 (1982) pp. 5-16.
U.S. Pharmacopeia, 16th ed., (1985), pp. 540-541, 2007.
Chaudry Imtiaz A.
Yim Zachary
Zupon Michael A.
Hazel Blondel
Magatti Anita W.
Miller Stephen I.
Nelson James R.
Schering Corporation
LandOfFree
Zinc-protamine-alpha interferon complex does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc-protamine-alpha interferon complex, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc-protamine-alpha interferon complex will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-130284